An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer.

Tianli HuiSainan LiHuimin WangXuejiao MaFurong DuWei GaoShan YangMeixiang SangZiyi LiRan DingYueping LiuCuizhi Geng

Published in: The oncologist (2023)

The present study highlights the unique features of HER2-low tumors in terms of their clinical characteristics as well as their gene expression profiles. HR status may influence the prognosis of patients with HER2-low expression, and patients with HR-positive/HER2-low expression may have a favorable outcome.

Keyphrases

poor prognosis
copy number
long non coding rna
genome wide
squamous cell carcinoma
locally advanced
childhood cancer